This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dupont Nutrition Biosciences Aps. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovations of Jeremy Labarge
Introduction
Jeremy Labarge is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant host cells. His work has implications for various applications in nutrition and biosciences.
Latest Patents
Jeremy Labarge holds a patent for a "Recombinant host cell expressing beta-galactosidase and/or transgalactosylating activity deficient in mannanase, cellulase and pectinase." This innovative host cell is capable of expressing a polypeptide with β-galactosidase and/or transgalactosylating activity while being modified to be deficient in cellulase, mannanase, and pectinase. This patent highlights his expertise in genetic engineering and its applications in biotechnology.
Career Highlights
Labarge is currently employed at DuPont Nutrition Biosciences Aps, where he continues to advance his research and development efforts. His work at DuPont has allowed him to collaborate with leading experts in the field, further enhancing his contributions to biotechnology.
Collaborations
Some of his notable coworkers include Jacob Flyvholm Cramer and Thomas Eisele. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Jeremy Labarge's contributions to biotechnology through his innovative patents and collaborative work at DuPont Nutrition Biosciences Aps exemplify the impact of dedicated inventors in advancing scientific knowledge and applications. His work continues to influence the field and inspire future innovations.